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Abstract: The synthesis of a plausible key intermediate for a bio-
mimetic asymmetric synthesis of indole alkaloid arboflorine is de-
scribed. The method featured the use of Ellman’s sulfinamide
chemistry for the establishment of the first chiral center, and the
Polonovski–Potier reaction for the formation of the a-aminonitrile
moiety.
Key words: indole alkaloids, biogenetic pathway, intermediate,
Polonovski–Potier reaction, Ellman’s sulfinamide
Indole alkaloids are a class of natural products widely dis-
tributed in plants that exhibit structural diversity and sig-
nificant biological activities.1 In 2006, Kam and co-
workers reported the isolation and structure elucidation of
arboflorine (1) as a minor alkaloid from the stem bark of
the Malayan Kopsia arborea.2 A notable feature of this
new alkaloid resides in that it represents a new subclass of
monoterpenoid indoles with a novel pentacyclic carbon
skeleton. Moreover, the incorporation of a third nitrogen
atom embedded within a tryptamine–secologanin-derived
monoterpenoid indole is also unusual (Figure 1).
Figure 1 Structure of arboflorine
In continuation of our interest in the asymmetric synthesis
of bioactive alkaloids,3 in particular piperidines4 and 2-
piperidinones,5 we have embarked on the asymmetric syn-
thesis of arboflorine (1), and the preliminary results on the
construction of a key intermediate are presented herein.
Our approach is based on the possible biogenetic pathway
proposed by Kam and co-workers,2 which highlighted the
cyclization of the key intermediate 2 (Scheme 1). In our
retrosynthetic analysis showed in Scheme 2, compound 7
was designed as a precursor of the key intermediate 6,
which is similar to the proposed biogenetic intermediate
2. The a-aminonitrile 7 was envisioned to be prepared
from piperideine 8 by Li’s cross-dehydrogenative-cou-
pling reaction (CDC)6 or the Polonovski–Potier reaction.7
Compound 8, in turn, could be accessible from chiral
amine 9 and indole derivative 10. Chiral amine 9 could be
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synthesized by chiral directing reduction of Ellman’s sul-
finamide.8,9
The synthesis started with the preparation of the protected
(RS,R)-N-tert-butanesulfinyl amine 9 by a known proce-
dure (Scheme 3).9 Ti(OEt)4-mediated9,10 condensation of
3-acetylpyridine (11) with Ellman’s (R)-sulfinamide 128
afforded sulfinimine 13 in 88% yield. Reduction of sulfin-
imine 13 with DIBAL-H in THF at –78 °C9 produced the
desired compound 9 in 89% yield.
Scheme 3 Synthesis of compound 9
The synthesis of segment 10 is outlined in Scheme 4,
which started with 2-(indol-3-yl)acetic acid (14). Reduc-
tion of 2-(indol-3-yl)acetic acid (14) with lithium alumi-
num hydride in THF gave the corresponding alcohol 15 in
96% yield, which was protected (TBSCl, Et3N, CH2Cl2) to
give compound 16 in 98% yield.
Scheme 4 Synthesis of compound 10
Oxidative conversion of 3-substituted indole 16 into
chloroindolenine 17 and use of this compound for the
functionalization at the carbon a to nitrogen by Kuehne’s
method11,12 (t-BuOCl, Et3N, THF; ZnCl2, lithium ethyl
tert-butyl malonate) provided compound 18 in 94% yield.
Successive treatment of compound 18 with trifluoroacetic
acid and potassium carbonate gave the desilylated and de-
carboxylated product 19 in an overall yield of 86%. Treat-
ment of indole-alcohol 19 with PPh3–CBr4 in CH2Cl2
proceeded chemoselectively to give the desired bromide
10 in 90% yield.
Scheme 5 Synthesis of compound 8
For the synthesis of compound 8, a CH2Cl2 solution of 9
and 10 was stirred at room temperature for seven days to
give the presumed pyridinium13 20 that was reduced with
NaBH4 in one pot to give piperideine14 21 in 70% yield.
N-Protection [(Boc)2O, Et3N, DMAP, MeCN] of the in-
dole nitrogen in compound 21 produced N-Boc derivative
8 in 91% yield (Scheme 5).
The next task was the regioselective introduction of a cy-
ano group at C-2 of the piperideine ring of compound 8 to
give compound 7. Attempted cyanation at C-2 of piperi-
deine 8 by Li’s CDC reaction6,15 using either CuCl, CuBr
or RuCl3 in the presence of O2, or H2O2, or t-BuOOH was
unsuccessful. It was found that the oxidative dehydroge-
nation occurred more readily at the carbon a to the tert-
butanesulfinamide group than at the piperidine a-carbon.
We then resorted to the Polonovski–Potier reaction.7,16,17
However, successive treatment of compound 8 with
MCPBA and NaCN gave only the corresponding sulfone
in 45% yield.
At this stage, modification of our synthetic plan by substi-
tution of the sulfoxide group of tert-butanesulfinamide by
a Boc group was indicated. For this purpose, compound 9
was treated with a 4 M HCl in methanol solution9 to give
amine dihydrochloride salt 22 that was protected
[(Boc)2O, Et3N, MeCN] to give compound (R)-23 in 86%
yield over two steps (Scheme 6). Successive treatment of
pyridine derivative 23 with bromide 10 and NaBH4 in
methanol afforded compound 24 in 64% yield. Treatment
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of compound 24 with (Boc)2O in the presence of Et3N and
DMAP in MeCN gave fully protected compound 25 in
92% yield (Scheme 6).
Scheme 6 Synthesis of the key intermediate 28
Compound 25 was subjected to Polonovski–Potier reac-
tion to generate 2-cyano-D3-piperideine 28. In the event,
piperideine 25 was treated with MCPBA, K2CO3 in
CH2Cl2 to give the N-oxide 26, which was treated with
TFAA in CH2Cl2, and the presumed iminium intermediate
27 was trapped by KCN in an aqueous AcOH–NaOAc
buffer solution (pH 4) to afford, in one pot, the desired ni-
trile 28 as an inseparable diastereomeric mixture in 74%
yield (Scheme 6). The diastereomeric ratio was deter-
mined to be 58:42 by 1H NMR analysis.18
In summary, an efficient synthesis of 2-cyano-D3-piperi-
deine 28, a plausible synthetic equivalent of the key inter-
mediate for a biomimetic synthesis of pentacyclic indole
alkaloid arboflorine (1) has been disclosed. Work is in
progress on the key decyanative cyclization16,19 and the
completion of the total synthesis of arboflorine (1). 
Supporting Information for this article is available online at
http://www.thieme-connect.com/ejournals/toc/synlett.
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